BUSINESS UPDATE: Celadon Pharmaceuticals Plc (CEL) Announces the appointment of a new CFO

We are delighted to announce that Jonathan Turner will be joining Celadon Pharmaceuticals Plc as Chief Financial Officer. Jonathan joins us from Oxford Instruments plc and will start a phased transition this month, before joining Celadon on a full time basis from February 2023.
The news of Jonathan’s appointment was written up by Stephanie Price in Cannabis Wealth , whose article can be read here: https://cannabiswealth.co.uk/2022/11/01/new-cfo-appointed-celadon-pharmaceuticals/
OTHER POSTS
-
PRESS: Britain could be getting high on the benefits of a full-scale medical cannabis industry
-
PRESS: British Pain Society features Celadon Pharmaceuticals Plc
-
PRESS: Celadon Pharmaceutical’s CEO Jim Short featured discussing new MHRA framework
-
PRESS: Inside huge top-secret legal cannabis facility hidden away in Birmingham that is the size of three football pitches